The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2025 | Looking forward to the upcoming Post-ASH 2025 MPNs Highlights webinar
In this video, Claire Harrison, MD, FRCP, FRCPath, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, invites viewers to register for the ‘Post-ASH MPNs Highlights’ webinar, taking place on 29 January 2026, to catch up on the latest developments in myeloproliferative neoplasms (MPNs) from the 67th ASH Annual Meeting and Exposition. The virtual event will feature distinguished faculty who will discuss the top abstracts presented at the event. This interview took place at the ASH 2025 Meeting, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
Please join us for the 2025 post-ASH, which will be in January 2026. We’ll have a great faculty with myself alongside Francesca Palandri and John Mascarenhas discussing with presenters of the top ASH abstracts. It’s a really good way to refresh and solidify if you’ve been able to watch ASH, but if you haven’t, it’s a quick way to catch up on what’s new and hot in MPN...
Please join us for the 2025 post-ASH, which will be in January 2026. We’ll have a great faculty with myself alongside Francesca Palandri and John Mascarenhas discussing with presenters of the top ASH abstracts. It’s a really good way to refresh and solidify if you’ve been able to watch ASH, but if you haven’t, it’s a quick way to catch up on what’s new and hot in MPN.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
